Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir

We assessed the efficacy and safety of ledipasvir/sofosbuvir plus ribavirin for 24 weeks in 9 human immunodeficiency virus/hepatitis C virus–coinfected patients who relapsed after receiving 12 weeks of treatment with ledipasvir/sofosbuvir. Eight of 9 (89%) achieved sustained virologic response 12 we...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Cooper, Curtis, Naggie, Susanna, Saag, Michael, Yang, Jenny C., Stamm, Luisa M., Dvory-Sobol, Hadas, Han, LingLing, Pang, Phillip S., McHutchison, John G., Dieterich, Douglas, Sulkowski, Mark
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967607/
https://ncbi.nlm.nih.gov/pubmed/27225242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw349
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items